Share this article:
Elsevier’s COVID-19 Hub Connects Researchers to Vital Resources
Elsevier’s Coronavirus Research Hub, a resource established to help researchers as they confront the COVID-19 outbreak, is providing life sciences researchers, clinical researchers and data scientists a broader range of biomedical research tools, from texting mining tools to COVID-19 related datasets.
The crisis created by the COVID-19 pandemic has everyone scrambling for answers. As the world clamors for widespread testing, effective treatments and preventive solutions, it can be hard to know where to start in the search for reliable insights. Elsevier’s Coronavirus Research Hub is aimed to be central place where researchers can go for content, data, knowledge and insight.
It’s critical at this time that the scientific community comes together to share vital information, which is why the hub is now offering individual researchers’ free access to a wide selection of Elsevier content, services and solutions, including ClinicalKey, Embase, SSRN, Pure COVID-19 Collaboration Center, Mendeley, Mendeley Data, Elsevier Text Mining (ETM), ScienceDirect COVID-19 related full-text articles, Professional Services and Pathway Studio (available in Mendeley Data). More tools such as Veridata EDC (Electronic Data Capture), Reaxys, Reaxys Medicinal Chemistry are currently being prepared to go live shortly. It is designed especially for clinical researchers, life science researchers and data scientists across the academic, government, non-profit and commercial sectors.
Updated regularly, Elsevier’s coronavirus portal currently includes:
- Over 14 million full text life science and health articles across publishers plus the CORD-19 dataset, searchable in Elsevier Text Mining (ETM)
- Pathway Studio data that visualizes COVID-19 molecular mechanism
- Embase – the regulators and authorities recommended biomedical databases surfacing precise drug-disease relationship, drug-drug interactions etc.
- and much more vaccines and drug discovery tools
Researchers looking for the latest COVID-19 research, resources ranging from full drug candidate profiles to animal models for testing, or those who are seeking collaborators will find support in the Coronavirus Research Hub.
Elsevier is hopeful that this resource can empower even more researchers to explore, manage, deliver, publish and share their innovations as we all work together to overcome this global crisis.
See what all the hub has to offer, and how to get complimentary access, here.
Stay up-to-date on the latest news and announcements from Elsevier. Learn about new product launches, programs and additions to our extensive list of books, journals and publisher tools.